pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Marketed
    avelumab
    Bavencio (avelumab)
    Merkel Cell Carcinoma EMD Serono Inc1 cat
  • Marketed
    axitinib SR
    AXPAXLI (axitinib)
    Wet (Neovascular / Exudative) Macular Degeneration$OCUL OCULAR THERAPEUTIX, INC1 cat
  • Marketed
    belantamab mafodotin
    Blenrep (belantamab mafodotin-blmf)
    Refractory Multiple Myeloma GlaxoSmithKline LLC1 cat
  • Phase 3
← prev
page 5 of 62
next →
Pain89
Neurology1
berubicin hydrochloride
berubicin hydrochloride
Recurrent Glioblastoma Multiforme (GBM)
$CNSP CNS Pharmaceuticals, Inc.
1 cat
  • Phase 2
    brentuximab vedotin
    Adcetris (brentuximab vedotin)
    Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic L…$PFE PFIZER INC1 cat
  • Marketed
    busulfan
    Myleran (busulfan)
    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Woodward Pharma Services LLC1 cat
  • Phase 2
    cadonilimab
    cadonilimab
    Hepatocellular Carcinoma Akeso Inc1 cat
  • pre_registration
    camizestrant
    camizestrant
    Human Epidermal Growth Factor Receptor 2 Negative Breast…$AZN ASTRAZENECA PLC1 cat
  • Marketed
    ceritinib
    Zykadia (ceritinib)
    Non-Small Cell Lung Cancer$NVS NOVARTIS AG1 cat
  • Phase 3
    cisplatin
    Hyalcis (cisplatin)
    Lip Cancer Privo Technologies Inc1 cat
  • Phase 3
    daraxonrasib
    daraxonrasib
    Non-Small Cell Lung Cancer$RVMD Revolution Medicines, Inc.1 cat
  • Marketed
    denosumab
    Prolia (denosumab)
    Glucocorticoid-Induced Osteoporosis$AMGN AMGEN INC1 cat
  • Phase 2
    dostarlimab
    Jemperli (dostarlimab-gxly)
    Rectal Cancer$GSK GSK plc1 cat
  • Marketed
    eflornithine hydrochloride
    Iwilfin (eflornithine hydrochloride)
    Neuroblastoma US WorldMeds LLC1 cat
  • Phase 2
    emavusertib hydrochloride
    emavusertib hydrochloride
    Chronic Lymphocytic Leukemia (CLL)$CRIS CURIS INC1 cat
  • Marketed
    etoposide
    Etopophos (etoposide)
    Small-Cell Lung Cancer H2-Pharma LLC1 cat
  • Marketed
    fruquintinib
    Fruzaqla (fruquintinib)
    Metastatic Colorectal Cancer Takeda Pharmaceuticals USA Inc1 cat
  • pre_registration
    fuzuloparib
    fuzuloparib [INN]
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Jiangsu Hengrui Pharmaceuticals Co Ltd1 cat
  • pre_registration
    iberdomide hydrochloride
    iberdomide hydrochloride
    Refractory Multiple Myeloma Bristol-Myers Squibb Co1 cat
  • Marketed
    imlunestrant tosylate
    Inluriyo (imlunestrant tosylate)
    Human Epidermal Growth Factor Receptor 2 Negative Breast… Eli Lilly and Co1 cat
  • Phase 2
    navlimetostat
    navlimetostat
    Non-Small Cell Lung Cancer Bristol-Myers Squibb Co1 cat
  • Marketed
    olaparib
    Lynparza (olaparib)
    Epithelial Ovarian Cancer AstraZeneca Pharmaceuticals LP1 cat
  • Marketed
    paltusotine hydrochloride
    Palsonify (paltusotine hydrochloride)
    Carcinoid Syndrome (Malignant Carcinoid Syndrome)$CRNX Crinetics Pharmaceuticals, Inc.1 cat
  • Marketed
    pertuzumab biosimilar
    Poherdy (pertuzumab-dpzb)
    Human Epidermal Growth Factor Receptor 2 Positive Breast… EirGenix Inc1 cat
  • Phase 3
    raludotatug deruxtecan
    raludotatug deruxtecan
    Adenocarcinoma Of The Gastroesophageal Junction Daiichi Sankyo Co Ltd1 cat
  • pre_registration
    sacituzumab govitecan
    Trodelvy (sacituzumab govitecan)
    Triple-Negative Breast Cancer (TNBC)$GILD GILEAD SCIENCES, INC.1 cat
  • Phase 2
    samuraciclib
    samuraciclib [INN]
    Breast Cancer Carrick Therapeutics Ltd1 cat
  • Phase 3
    serplulimab
    serplulimab
    Small-Cell Lung Cancer Shanghai Henlius Biotech Inc1 cat
  • Marketed
    sevabertinib
    Hyrnuo (sevabertinib)
    Non-Small Cell Lung Cancer Bayer AG1 cat
  • Phase 2
    soficabtagene geleucel
    soficabtagene geleucel [INN]
    T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphobla… Wugen Inc1 cat